Abstract
Several human milk oligosaccharides inhibit human pathogens in vitro and in animal models. In an infant, the ability of these oligosaccharides to offer protection from enteric pathogens would require that they withstand structural modification as they pass through the alimentary canal or are absorbed and excreted in urine. We investigated the fate of human milk oligosaccharides during transit through the alimentary canal by determining the degree to which breast-fed infants’ urine and fecal oligosaccharides resembled those of their mothers’ milk Oligosaccharide profiles of milk from 16 breast-feeding mothers were compared with profiles of stool and urine from their infants. Results were compared with endogenous oligosaccharide profiles obtained from the urine and feces of age-, parity-, and gender-matched formula-fed infants. In all cases, oligosaccharides were extracted, purified, reduced, and separated into acidic and neutral species; the latter were perbenzoylated and subjected to reversed-phase high-performance liquid chromatography. Structures were determined by mass spectrometry after debenzoylation. Among breast-fed infants, concentrations of oligosaccharides were higher in feces than in mothers’ milk, and much higher in feces than in urine. Urinary and fecal oligosaccharides from breast-fed infants resembled those in their mothers’ milk Those from formula-fed infants did not resemble human milk oligosaccharides, were found at much lower concentrations, and probably resulted from remodeling of intestinal glycoconjugates or from intestinal bacteria. Most of the human milk oligosaccharides survived transit through the gut, and some were absorbed and then excreted into the urine intact, implying that inhibition of intestinal and urinary pathogens by human milk oligosaccharides is quite likely in breast-fed infants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Chaturvedi P, Warren CD, Ruiz-Palacios GM, Pickering LK, Newburg DS. Milk oligosaccharide profiles by reversed phase HPLC of their perbenzoylated derivatives. Anal Biochem 1997;251:89–97.
Chester MA, Lundblad A, Rowland M, Sjoblad S. Urinary excretion of oligosaccharides by premature and full-term babies and adults. In: Yamakawa T, Osawa T, Handa S, editors. Glycoconjugates. Proceedings of the 61hInternational Symposium on Glycoconjugates; Tokyo, Japan; 1981. Abstr 213a.
Chu S-HW, Walker WA. Bacterial toxin interaction with the developing intestine. Gastroenterology 1993;104:916–925.
Lundblad A, Chester MA. Blood group active haptens in urine and feces. Adv Exp Med Biol 1988;228: 73–81.
Newburg DS. Oligosaccharides and glycoconjugates in human milk: Their role in host defense. J Mammary Gland Biol Neoplasia 1996;1:271–283.
Rudloff S, Diekmann L, Kunz C. Urinary excretion of lactose and complex oligosaccharides in preterm infants. In: Allen L, King J, Lönnerdal B, editors. Nutrient Regulation During Pregnancy, Lactation, and Infant Growth. New York: Plenum Press; 1994.
Sabharwal H, Nilsson B, Chester MA. Sjoblad S, Lundblad A. Blood group-specific oligosaccharides from faeces of a blood group A breast-fed infant. Mol Immunol 1984;11:1105–1112.
Sabharwal H, NilssonBChester MA, Lindh F, Gronberg G, Sjoblad S, Lundblad A. Oligosaccharides from faeces of a blood-groupBbreast-fed infant. Carbohydr Res 1988;178:145–154.
SabharwalHSjoblad S, Lundblad A. Affinity chromatographic identification and quantitation of blood group A-active oligosaccharide in human milk and feces of breast-fed infants. J Pediatr Gastroenterol Nutr 1991a;12:474–479.
Sabharwal H, Sjoblad S, Lundblad A. Sialylated oligosaccharides in human milk and feces of preterm, full-term, and weaning infants. J Pediatr Gastroenterol Nutr 1991b;12:480–484.
Warren C, Chaturvedi P, Wiederschain G, Pickering L, Ruiz-Palacios G, NewburgD.Changes in human milk oligosaccharides during lactation. Glycobiology 1996;6:730.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chaturvedi, P., Warren, C.D., Buescher, C.R., Pickering, L.K., Newburg, D.S. (2001). Survival of Human Milk Oligosaccharides in the Intestine of Infants. In: Newburg, D.S. (eds) Bioactive Components of Human Milk. Advances in Experimental Medicine and Biology, vol 501. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1371-1_39
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1371-1_39
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5521-2
Online ISBN: 978-1-4615-1371-1
eBook Packages: Springer Book Archive